Location History:
- Taichung Hsien, TW (2013 - 2015)
- Taipei County, TW (2015)
Company Filing History:
Years Active: 2013-2015
Title: Jiunn-Liang Ko: Innovator in Cancer Treatment
Introduction
Jiunn-Liang Ko is a prominent inventor based in Taichung Hsien, Taiwan. He has made significant contributions to the field of biotechnology, particularly in cancer treatment. With a total of 3 patents, his work focuses on innovative methods to inhibit EGF receptor activity, which is crucial in cancer progression.
Latest Patents
One of Jiunn-Liang Ko's latest patents provides a method for inhibiting EGF receptor activity. This method involves contacting an EGF receptor with an immunomodulatory protein (GMI) or a recombinant thereof. Additionally, he has developed a method for treating the invasion and metastasis of cancer cells. This treatment comprises administering an effective amount of the immunomodulatory protein (GMI) to a subject in need of such treatment.
Career Highlights
Jiunn-Liang Ko is associated with Mycomagic Biotechnology Co., Ltd., where he continues to advance his research and development efforts. His innovative approaches have the potential to significantly impact cancer therapies and improve patient outcomes.
Conclusion
Jiunn-Liang Ko's contributions to biotechnology and cancer treatment exemplify the importance of innovation in addressing critical health challenges. His work continues to inspire advancements in medical science and patient care.